Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner

Robin E. Frink, Michael Peyton, Joan H. Schiller, Adi F. Gazdar, Jerry W. Shay, John D. Minna

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner'. Together they form a unique fingerprint.

Medicine & Life Sciences